MarketPeel
Insider Trading Intelligence
LE

Luke Evnin

HOWL
DIRECTOR · WEREWOLF THERAPEUTICS, INC. · CIK 0001134657
FILING MIX · LIFETIME16%/84%
BUYS
20
SELLS
103
TOTAL VALUE
$28.58M
COMPANIES
4
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
6,180,232
AVG SELL PX
$0.98
TRADE KIND
SHOWING 123 / 123
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
72 backtested trades · 8 horizons · 180 pending
Forward-return performance of every backtestable P/S trade by Luke Evnin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d72+73.61%-8.11%+0.08%-7.84%-7.91%-4.62
14d72+72.22%-13.56%+0.34%-11.95%-11.08%-4.95
30d72+76.39%-19.62%+0.52%-18.38%-23.95%-6.88
60d72(6 pending)+80.30%-25.05%+0.96%-26.02%-37.38%-6.81
90d72(13 pending)+67.80%-9.20%-0.43%-8.77%-28.56%-1.61
180d72(22 pending)+96.00%-46.45%+7.99%-53.13%-53.25%-17.15
1y72(68 pending)+75.00%-46.95%+11.35%-58.30%-61.51%
2y72(71 pending)+0.00%-83.78%+0.44%-84.22%-84.22%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HOWL · 143,199 shares · as of Jun 29, 2026
01,984,9933,969,9855,954,9787,939,970202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 103 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
157,084$0.30$47.1K143,199Jun 29, 2026Jun 29, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
76,928$0.37$28.5K300,283Jun 9, 2026Jun 10, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
60,547$0.40$24.2K377,211Jun 8, 2026Jun 8, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
24,946$0.40$10.0K437,758Jun 5, 2026Jun 8, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,072$0.44$8.8K462,704Jun 4, 2026Jun 8, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
29,749$0.42$12.5K482,776Jun 3, 2026Jun 3, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
29,595$0.45$13.3K512,525Jun 2, 2026Jun 3, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
80,459$0.47$37.8K542,120Jun 1, 2026Jun 3, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
32,556$0.45$14.7K622,579May 29, 2026May 29, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
27,698$0.46$12.7K655,135May 28, 2026May 29, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
80,852$0.48$38.8K682,833May 27, 2026May 29, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
67,950$0.47$31.9K763,685May 26, 2026May 26, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
87,425$0.45$39.3K831,635May 22, 2026May 26, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
36,387$0.42$15.3K919,060May 21, 2026May 26, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
85,895$0.43$36.9K955,447May 20, 2026May 20, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
62,970$0.45$28.3K1,041,342May 19, 2026May 20, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
22,184$0.50$11.1K1,104,312May 18, 2026May 20, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
44,679$0.54$24.1K1,126,496May 13, 2026May 13, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
67,885$0.64$43.4K1,171,175May 12, 2026May 12, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
33,948$0.67$22.7K1,239,060May 11, 2026May 12, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
305,741$0.70$214.0K1,273,008May 8, 2026May 12, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
79,086$0.63$49.8K1,578,749May 7, 2026May 7, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
14,635$0.66$9.7K1,657,835May 6, 2026May 7, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,860$0.69$4.7K1,672,470May 5, 2026May 7, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
47,963$0.72$34.5K1,679,330May 4, 2026May 4, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
58,394$0.73$42.6K1,727,293May 1, 2026May 4, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
168,262$0.72$121.1K1,785,687Apr 30, 2026May 4, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
56,559$0.69$39.0K1,953,949Apr 29, 2026Apr 29, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
95,412$0.73$69.7K2,010,508Apr 28, 2026Apr 29, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
53,940$0.85$45.8K2,105,920Apr 27, 2026Apr 29, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
38,782$0.54$20.9K2,159,860Jan 16, 2026Jan 20, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
37,413$0.55$20.6K2,198,642Jan 15, 2026Jan 15, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
30,616$0.57$17.5K2,236,055Jan 14, 2026Jan 15, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
43,198$0.55$23.8K2,266,671Jan 13, 2026Jan 15, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
58,980$0.57$33.6K2,309,869Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
22,500,0000Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
6,000,0000Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
5,914,1977,570,168Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
5,000,0000Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,577,1199,147,287Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,112,777$18.00$20.03M10,260,064Jan 12, 2026Jan 14, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
1,314,2621,655,971Jan 12, 2026Jan 14, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
24,678$0.61$15.1K2,368,849Jan 9, 2026Jan 12, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,716$0.63$4.9K2,393,527Jan 8, 2026Jan 12, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
11,915$0.64$7.6K2,401,243Jan 7, 2026Jan 7, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
40,761$0.65$26.5K2,413,158Jan 6, 2026Jan 7, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
18,378$0.64$11.8K2,453,919Jan 5, 2026Jan 7, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
18,568$0.63$11.7K2,472,297Jan 2, 2026Jan 2, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
24,962$0.62$15.5K2,490,865Dec 31, 2025Jan 2, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
34,847$0.61$21.3K2,515,827Dec 30, 2025Jan 2, 2026View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
108,606$0.61$66.2K2,550,674Dec 29, 2025Dec 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
35,632$0.63$22.4K2,659,280Dec 26, 2025Dec 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
16,310$0.65$10.6K2,694,912Dec 24, 2025Dec 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
71,428$0.63$45.0K2,711,222Dec 23, 2025Dec 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
59,307$0.69$40.9K2,782,650Dec 22, 2025Dec 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,983$1.14$11.4K2,841,957Dec 17, 2025Dec 17, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
14,548$1.05$15.3K2,851,940Dec 16, 2025Dec 17, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
23,640$1.07$25.3K2,866,488Dec 15, 2025Dec 17, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,858$1.08$19.3K2,890,128Dec 12, 2025Dec 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
28,009$1.07$30.0K2,907,986Dec 11, 2025Dec 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
37,104$1.06$39.3K2,935,995Dec 10, 2025Dec 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
44,570$1.01$45.0K2,973,099Dec 9, 2025Dec 9, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
34,041$0.99$33.7K3,017,669Dec 8, 2025Dec 9, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
16,568$0.97$16.1K3,051,710Dec 5, 2025Dec 9, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
53,416$0.97$51.8K3,068,278Dec 4, 2025Dec 4, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
36,726$0.87$32.0K3,121,694Dec 3, 2025Dec 4, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
38,043$0.89$33.9K3,158,420Dec 2, 2025Dec 4, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
39,096$0.94$36.8K3,196,463Dec 1, 2025Dec 1, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
13,014$0.99$12.9K3,235,559Nov 28, 2025Dec 1, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
38,978$0.98$38.2K3,248,573Nov 26, 2025Dec 1, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
27,297$0.92$25.1K3,287,551Nov 25, 2025Nov 25, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
56,992$0.98$55.9K3,314,848Nov 24, 2025Nov 25, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
41,287$0.83$34.3K3,371,840Nov 21, 2025Nov 25, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
26,411$0.89$23.5K3,413,127Nov 20, 2025Nov 20, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
42,566$0.94$40.0K3,439,538Nov 19, 2025Nov 20, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
33,776$0.93$31.4K3,482,104Nov 18, 2025Nov 20, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
36,621$0.95$34.8K3,515,880Nov 17, 2025Nov 17, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
39,560$0.93$36.8K3,552,501Nov 14, 2025Nov 17, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
58,372$0.98$57.2K3,592,061Nov 13, 2025Nov 17, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
26,101$1.09$28.5K3,650,433Nov 12, 2025Nov 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
35,818$1.14$40.8K3,676,534Nov 11, 2025Nov 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
31,172$1.18$36.8K3,712,352Nov 10, 2025Nov 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
43,950$1.11$48.8K3,743,524Nov 7, 2025Nov 12, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
34,947$1.21$42.3K3,787,474Nov 6, 2025Nov 6, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
30,774$1.22$37.5K3,822,421Nov 5, 2025Nov 6, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
90,164$1.22$110.0K3,853,195Nov 4, 2025Nov 6, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
60,369$1.29$77.9K3,943,359Nov 3, 2025Nov 3, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
73,192$1.28$93.7K4,003,728Oct 31, 2025Nov 3, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
55,795$1.43$79.8K4,076,920Oct 30, 2025Nov 3, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
86,154$1.55$133.5K4,132,715Oct 29, 2025Oct 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
44,327$1.64$72.7K4,218,869Oct 28, 2025Oct 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
46,664$1.72$80.3K4,263,196Oct 27, 2025Oct 29, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
27,00027,000Jun 12, 2025Jun 13, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASE
28,113$0.09$2.5K4,312,285Mar 27, 2025Apr 30, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
2,425$1.05$2.5K4,309,860Mar 27, 2025Apr 30, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
24,0980Mar 27, 2025Apr 30, 2025View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
4,0150Mar 27, 2025Apr 30, 2025View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
21,787$20.23$440.8K4,381,062Dec 11, 2024Dec 12, 2024View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
22,935$20.77$476.4K4,402,849Dec 10, 2024Dec 12, 2024View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,50017,500May 24, 2024May 24, 2024View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
13,20013,200Jun 21, 2023Jun 23, 2023View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,60011,600Jun 1, 2022Jun 3, 2022View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
100,000$20.00$2.00M4,425,784Nov 2, 2021Nov 4, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
3,683,2410Nov 2, 2021Nov 4, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
3,816,7603,816,760Nov 2, 2021Nov 4, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
509,0244,325,784Nov 2, 2021Nov 4, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
27,617,6750Nov 2, 2021Nov 4, 2021View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASE
2,756,0733,217,481May 4, 2021May 6, 2021View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
23,892,6770May 4, 2021May 6, 2021View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASE
915,8924,133,373May 4, 2021May 6, 2021View →
HOWL
WEREWOLF THERAPEUTICS, INC.
SALE
7,939,9700May 4, 2021May 6, 2021View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASE
150,799$16.00$2.41M4,284,172May 4, 2021May 6, 2021View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,20023,200Apr 30, 2021May 3, 2021View →
HOWL
WEREWOLF THERAPEUTICS, INC.
PURCHASE
7,939,9707,939,970Dec 23, 2020May 6, 2021View →
DYN
DYNE THERAPEUTICS, INC.
PURCHASE
4,614,9434,614,943Sep 21, 2020Sep 23, 2020View →
DYN
DYNE THERAPEUTICS, INC.
SALE
13,980,9920Sep 21, 2020Sep 23, 2020View →
DYN
DYNE THERAPEUTICS, INC.
PURCHASE
91,08191,081Sep 21, 2020Sep 23, 2020View →
DYN
DYNE THERAPEUTICS, INC.
SALE
743,0760Sep 21, 2020Sep 23, 2020View →
DYN
DYNE THERAPEUTICS, INC.
SALE
275,9320Sep 21, 2020Sep 23, 2020View →
DYN
DYNE THERAPEUTICS, INC.
SALE
70,4920Sep 21, 2020Sep 23, 2020View →
DYN
DYNE THERAPEUTICS, INC.
PURCHASE
245,279245,279Sep 21, 2020Sep 23, 2020View →
DYN
DYNE THERAPEUTICS, INC.
SALE
1,326,3130Sep 21, 2020Sep 23, 2020View →
DYN
DYNE THERAPEUTICS, INC.
SALE
26,1760Sep 21, 2020Sep 23, 2020View →
Other insiders · HOWL
Loading peer insiders…
About this filer
CIK 0001134657
ROLE
Director
PRIMARY
HOWL
COMPANIES
4
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001134657DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback